Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan Railway board adopts plan to raise fares by 26.8% on average
02/05/2025 08:17 PM - Culture
Taiwan artist sings homeland's praises at French comics festival
02/05/2025 07:45 PM - Science & Tech
Taiwanese scientists find new pancreatic cancer signaling mechanism
02/05/2025 07:18 PM - Politics
Visiting Estonian lawmaker proposes closer drone cooperation with Taiwan
02/05/2025 06:18 PM - Cross-Strait
3 active military officers indicted for leaking intelligence to China
02/05/2025 06:17 PM